Wound Care (Pharmacies) - South America

  • South America
  • Revenue in the Wound Care market is projected to reach US$58.83m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.76%, resulting in a market volume of US$56.63m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.14 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in South America is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Wound Care (Pharmacies) market in South America are shifting towards products that offer advanced wound healing and faster recovery. Customers are increasingly seeking wound care products that are easy to use, provide effective pain relief, and promote faster healing. This shift in preferences is driven by the growing awareness among consumers about the importance of proper wound care and the desire to minimize the risk of infections and complications. Trends in the market indicate a growing demand for innovative wound care products in South America. Manufacturers are introducing new products with advanced technologies such as antimicrobial dressings, negative pressure wound therapy, and bioactive wound dressings. These products offer enhanced wound healing capabilities and are gaining popularity among both healthcare professionals and consumers. Additionally, there is an increasing focus on the development of wound care products that are cost-effective and easily accessible to consumers. Local special circumstances in South America are also contributing to the growth of the Wound Care (Pharmacies) market. The region has a high prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, which require specialized wound care management. This has created a significant demand for wound care products in the region. Furthermore, the increasing geriatric population in South America is also driving the demand for wound care products, as older adults are more susceptible to chronic wounds and require specialized care. Underlying macroeconomic factors are playing a crucial role in the development of the Wound Care (Pharmacies) market in South America. The region is experiencing economic growth, which has led to an increase in healthcare spending. This has resulted in improved access to healthcare services, including wound care, and has created a favorable environment for the growth of the market. Additionally, the increasing investment in healthcare infrastructure and the expansion of pharmacy chains in South America are further driving the market growth. In conclusion, the Wound Care (Pharmacies) market in South America is witnessing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards advanced wound care products, the introduction of innovative technologies, the high prevalence of chronic wounds, and the economic growth in the region are all contributing to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)